ozanimod 37-Day Starter Kit
- RxCUI
- 2288430
- RxNorm name
- ozanimod 37-Day Starter Kit
- Display name
- ozanimod 37-Day Starter Kit
- Full name
- ozanimod 37-Day Starter Kit
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:09
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZEPOSIA 7-Day Starter Pack | OZANIMOD HYDROCHLORIDE | Celgene Corporation | 93ce2fab-edfb-4804-8074-963071de51e4 | 2026-04-16 | Warnings, Adverse reactions | 2288430 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 93ce2fab-edfb-4804-8074-963071de51e4 | ozanimod 37-Day Starter Kit | PSN | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |
| 93ce2fab-edfb-4804-8074-963071de51e4 | ozanimod 37-Day Starter Kit (7-Day Starter Pack and 0.92 MG 30 count Bottle) | SY | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |
| 93ce2fab-edfb-4804-8074-963071de51e4 | {4 (ozanimod 0.23 MG Oral Capsule) / 3 (ozanimod 0.46 MG Oral Capsule) / 30 (ozanimod 0.92 MG Oral Capsule) } Pack | GPCK | 25 | These highlights do not include all the information needed to use ZEPOSIA safely and effectively. See full prescribing information for ZEPOSIA. ZEPOSIA ® (ozanimod) capsules, for oral use Initial U.S. Approval: 2020 | 20260416 |